<DOC>
	<DOCNO>NCT00612326</DOCNO>
	<brief_summary>The purpose study find MRI PET scan truly stage patient bladder cancer . Both scan use new way find disease grown beyond bladder . The radioactive tracer use PET scan call C-11 Acetate . We want see PET scan able take picture inside body well scan CT scan MRI . Therefore , finding PET scan compare imaging study well surgical finding .</brief_summary>
	<brief_title>Feasibility Evaluation Magnetic Resonance Imaging Positron Emission Tomography Bladder Cancer Diagnosis Staging</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Transitional Cell</mesh_term>
	<criteria>Thirty ( 30 ) patient enrol pilot study . All patient clinical histologic diagnosis bladder cancer active disease identify within bladder time consent image . Patients primary resectable lesion , localize regionally extensive disease eligible residual disease bladder time image . All patient consent treatment MSKCC Prior pelvic radiation bladder cancer Nontransitional cell histology Patients deem appropriate surgical candidate Patients pregnant lactate Patients tolerate PET MRI scanner duration study . Patients deem unable receive contrast enhance CT remain eligible . Vulnerable patient ( minor , mentally retarded , prisoner , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>